Skip to main content

1620 INVESTMENT ADVISORS, INC.

Position in TEVA — Teva Pharmaceutical Industries Ltd

CIK 1907281 PLYMOUTH, MA

Position in TEVA

as of Jun 30, 2026 · filed Jul 14, 2026
Position Value
$53,428
+$5,929 QoQ
Shares Held
1,577
0.0% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.05%
of 13F equity value
Holder Rank
#534
of 671 holders
Holding Since
Jun 2024
9 quarters on record
Voting authority Sole 50% Shared 0% None 50%

Common Shares in TEVA Over Time

Shares Held

Position Value (USD)

Position in Drug Manufacturers - Specialty & Generic

Healthcare · as of Jun 30, 2026

1620 INVESTMENT ADVISORS, INC. holds $895,573 across 9 Drug Manufacturers - Specialty & Generic names. TEVA ranks #4 (6.0% of the industry book) .

# Ticker Company Shares Value (USD) Open
4 TEVA
Teva Pharmaceutical Industries Ltd
This page
1,577 $53,428

All Filings in TEVA

Export CSV
9 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $53,428 1,577
2026-03-31 $47,499 1,577
2025-12-31 $49,218 1,577
2025-09-30 $1,656 82
2025-06-30 $1,374 82
2025-03-31 $1,260 82
2024-12-31 $1,807 82
2024-09-30 $1,477 82
2024-06-30 $1,625 100